New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 16, 2014
09:13 EDTABTAbbott sees accelerating sales growth in 2H14
The company expects to achieve double digit EPS growth this year despite reporting an unfavorable Exchange impact of 3% on sales in Q1. The company said it is "right on track" with the sales progression it expected in January with sales growth before exchange essentially the same as its planned forecast. Abbott expects continued momentum in Established Pharmaceuticals, particularly in Brazil and India. It sees continued in improvement in growth rate with emerging markets becoming a larger component of the business. Expects double sales growth and operating margin for Nutrition in 2H14. Comments taken from Q1 earnings conference call.
News For ABT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
07:37 EDTABTPfizer replaces AbbVie as top global pharma pick at Jefferies
Subscribe for More Information
May 19, 2015
08:02 EDTABTAbbott announces CE Mark for new advancement of Absorb stent system
Subscribe for More Information
May 18, 2015
11:23 EDTABTFitch downgrades Abbott's L-T IDR to A; outlook revised to stable
Subscribe for More Information
May 14, 2015
09:41 EDTABTLeerink medical devices analyst holds a cardiology luncheon meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use